Issue

Vol. 35 No. 5 (2023): Vol 35 Issue 5, 2023

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Investigation of Guanidine-Curcumin Complex based on Quantum Chemicals, Pharmacokinetics and Molecular Docking Simulation against Breast Cancer: A Theoretical Approach

https://doi.org/10.14233/ajchem.2023.27805
Thimma Mohan Viswanathan
Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil-626126, India
https://orcid.org/0000-0002-3463-0735
Azar Zochedh
Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil-626126, India
https://orcid.org/0000-0001-9818-5071
Kaliraj Chandran
Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil-626126, India
https://orcid.org/0000-0002-1226-4869
Sureba Sukumaran
Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil-626126, India
https://orcid.org/0000-0003-0780-9577
Asath Bahadur Sultan
Condensed Matter Physics Laboratory, Department of Physics, International Research Centre, Kalasalingam Academy of Research and Education, Krishnankoil-626126, India
https://orcid.org/0000-0002-4552-7354
Thandavarayan Kathiresan
Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil-626126, India
https://orcid.org/0000-0002-0956-9063

Corresponding Author(s) : Asath Bahadur Sultan

s.asathbahadur@gmail.com

Asian Journal of Chemistry, Vol. 35 No. 5 (2023): Vol 35 Issue 5, 2023

Abstract

The breast cancer is the foremost reason for cancer death rates and incidence globally in women. Combinatorial therapy is a significant practice in the cancer treatment process. The combination of two molecules appears efficient and inhibits a variety of cancer-causing mechanisms. In present investigation, combination of guanidine and curcumin was employed as a synergistic drug against the breast cancer. Firstly, the combined structure of guanidine-curcumin was built and the structure was optimized through density functional computation in B3LYP/6-311++G (d,p) level. The electronic spectrum observed in CAM-B3LYP with same basis set and the transition observed was π→π*. The chemical reactivity and structural stability of guanidine-curcumin was evaluated through molecular orbitals and molecular electrostatic potential. The energy gap calculated for the complex structure was 3.45963 eV, which confirms the better reactivity of the complex. The atomic charges of each atom associated with the complex was assessed through Mulliken charge distribution. Further, the breast cancer inhibitory potential of guanidine-curcumin complex was evaluated through in silico molecular docking studies. The docking simulation showed that the complex structure has good binding ability against target breast tumor proteins when compared with standard drug. The physico-chemical, absorption, metabolism, distribution, excretion and toxicity characteristics of complex structure exhibited the drug-likeness properties and showed its safety feature. These, in silico findings will be beneficial for further in vitro and in vivo studies against breast cancer.

Keywords

Guanidine Curcumin Breast cancer Density function theory ADMET
Viswanathan, T. M., Zochedh, A., Chandran, K., Sukumaran, S., Sultan, A. B., & Kathiresan, T. (2023). Investigation of Guanidine-Curcumin Complex based on Quantum Chemicals, Pharmacokinetics and Molecular Docking Simulation against Breast Cancer: A Theoretical Approach. Asian Journal of Chemistry, 35(5), 1189–1198. https://doi.org/10.14233/ajchem.2023.27805
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. R.L. Siegel, K.D. Miller and A. Jemal, CA Cancer J. Clin., 69, 7 (2019); https://doi.org/10.3322/caac.21551
  2. N. Arunadevi, M. Swathika, B.P. Devi, P. Kanchana, S.S. Sundari, S.J. Kirubavathy, P. Subhapriya and E.R. Kumar, Surf. Interfaces, 24, 101094 (2021); https://doi.org/10.1016/j.surfin.2021.101094
  3. A. Allegra, V. Innao, S. Russo, D. Gerace, A. Alonci and C. Musolino, Cancer Invest., 35, 1 (2017); https://doi.org/10.1080/07357907.2016.1247166
  4. Z.Y. Wang and L. Yin, Mol. Cell. Endocrinol., 418, 193 (2015); https://doi.org/10.1016/j.mce.2015.04.017
  5. J. Kiani, A. Khan, H. Khawar, F. Shuaib and S. Pervez, Pathol. Oncol. Res., 12, 223 (2006); https://doi.org/10.1007/BF02893416
  6. T.M. Viswanathan, K. Chitradevi, A. Zochedh, R. Vijayabhaskar, S. Sukumaran, S. Kunjiappan, N.S. Kumar, K. Sundar, E. Babkiewicz, P. Maszczyk and T. Kathiresan, Cancers, 14, 3490 (2022); https://doi.org/10.3390/cancers14143490
  7. G. Palma, G. Frasci, A. Chirico, E. Esposito, C. Siani, C. Saturnino, C. Arra, G. Ciliberto, A. Giordano and M. D’Aiuto, Oncotarget, 6, 26560 (2015); https://doi.org/10.18632/oncotarget.5306
  8. J. Chen, Y. Yao, C. Gong, F. Yu, S. Su, J. Chen, B. Liu, H. Deng, F. Wang, L. Lin, H. Yao, F. Su, K.S. Anderson, Q. Liu, M.E. Ewen, X. Yao and E. Song, Cancer Cell, 19, 541 (2011); https://doi.org/10.1016/j.ccr.2011.02.006
  9. N.I. Ziedan, R. Hamdy, A. Cavaliere, M. Kourti, F. Prencipe, A. Brancale, A.T. Jones and A.D. Westwell, Chem. Biol. Drug Des., 90, 147 (2017); https://doi.org/10.1111/cbdd.12936
  10. I. Koca, A. Özgür, M. Er, M. Gümüs, K. Açikalin Coskun and Y. Tutar, Eur. J. Med. Chem., 122, 280 (2016); https://doi.org/10.1016/j.ejmech.2016.06.032
  11. M.E. Vaschetto, B.A. Retamal and A.P. Monkman, J. Mol. Struct. THEOCHEM, 468, 209 (1999); https://doi.org/10.1016/S0166-1280(98)00624-1
  12. A. Zochedh, A. Shunmuganarayanan and A.B. Sultan, J. Mol. Struct., 1274, 134402 (2023); https://doi.org/10.1016/j.molstruc.2022.134402
  13. S. Thangarasu, A. Chitradevi, V. Siva, A. Shameem, A. Murugan, T.M. Viswanathan, S. Athimoolam and S.A. Bahadur, Polycycl. Aromat. Compds., (2022); https://doi.org/10.1080/10406638.2022.2064883
  14. A. Kouranov, L. Xie, J. de la Cruz, L. Chen, J. Westbrook, P.E. Bourne and H.M. Berman, Nucleic Acids Res., 34(suppl_1), D302 (2006); https://doi.org/10.1093/nar/gkj120
  15. S. Dallakyan and A.J. Olson, Methods Mol. Biol., 1263, 243 (2015); https://doi.org/10.1007/978-1-4939-2269-7_19
  16. K. Al-Azzam, Kompleksnoe Ispolzovanie Mineralnogo Syra, 325, 14 (2023); https://doi.org/10.31643/2023/6445.13
  17. T.M. Kolev, E.A. Velcheva, B.A. Stamboliyska and M. Spiteller, Int. J. Quantum Chem., 102, 1069 (2005); https://doi.org/10.1002/qua.20469
  18. V. Siva, S.S. Kumar, A. Shameem, M. Raja, S. Athimoolam and S.A. Bahadur, J. Mater. Sci. Mater. Electron., 28, 12484 (2017); https://doi.org/10.1007/s10854-017-7070-8
  19. S. Sukumaran, A. Zochedh, T.M. Viswanathan, A.B. Sultan and T. Kathiresan, Polycycl. Arom. Compounds, (2023); https://doi.org/10.1080/10406638.2022.2164018
  20. M. Priya, A. Zochedh, K. Arumugam and A.B. Sultan, Chemistry Africa, 6, 287 (2022); https://doi.org/10.1007/s42250-022-00508-z
  21. A. Zochedh, M. Priya, C. Chakaravarthy, A.B. Sultan and T. Kathiresan, Polycycl. Arom. Compds., (2022); https://doi.org/10.1080/10406638.2022.2118332
  22. S. Thangarasu, V. Siva, S. Kannan, S.A. Bahadur and S. Athimoolam, Polycycl. Arom. Compds., (2022); https://doi.org/10.1080/10406638.2022.2130374
  23. W. Tian, C. Chen, X. Lei, J. Zhao and J. Liang, Nucleic Acids Res., 46(W1), W363 (2018); https://doi.org/10.1093/nar/gky473
  24. S.G. Nayfield, J.E. Karp, L.G. Ford, F.A. Dorr and B.S. Kramer, J. Natl. Cancer Inst., 83, 1450 (1991); https://doi.org/10.1093/jnci/83.20.1450
  25. A. Zochedh, K. Chandran, M. Priya, A.B. Sultan and T. Kathiresan, J. Mol. Struct., 1285, 135403 (2023); https://doi.org/10.1016/j.molstruc.2023.135403
  26. LIGAND Design, Pharmacophore and Ligand-based Design with Biovia Discovery Studio®, BIOVIA, California (2014).
  27. A. Zochedh, M. Priya, A. Shunmuganarayanan, A.B. Sultan and T. Kathiresan, J. Mol. Struct., 1282, 135113 (2023);
  28. https://doi.org/10.1016/j.molstruc.2023.135113
  29. U. Norinder and C.A.S. Bergström. ChemMedChem, 1, 920 (2006); https://doi.org/10.1002/cmdc.200600155
  30. K.R. Sharmili Banu, I.M. Priya and A.S. Azar Zochedh, Asian J. Biotechnol. Genetic Eng., 5, 9 (2022).
  31. K. Chandran, D.I. Shane, A. Zochedh, A.B. Sultan and T. Kathiresan, In Silico Pharmacol., 10, 14 (2022); https://doi.org/10.1007/s40203-022-00130-4
  32. L.L.G. Ferreira and A.D. Andricopulo, Drug Discov. Today, 24, 1157 (2019); https://doi.org/10.1016/j.drudis.2019.03.015
Read More
Author biographies is not available.
Download
AJC-35-5-20
Statistic
Read Counter : 1 Download : 0